+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Oral Anti-diabetes Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Pre Book Price: $ 5216

Original Price: $ 5795

Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels of blood glucose, which can cause severe damage to blood vessels, heart, kidneys, nerves, and eyes.

Diabetes is also called hyperglycemia or raised blood sugar. Insulin is a hormone that regulates the blood sugar level in body. Continuous increase in blood sugar leads to diabetes. Uncontrollable diabetes can damage the nervous system and other body systems.

Diabetes is of two types: type 1 and type 2. Type 1 diabetes, also known as juvenile diabetes or insulin-dependent diabetes, arises when the immune system misguidedly attacks and kills the beta cells of the pancreas. In type 1 diabetes, little or no insulin is released into the body, owing to this sugar builds up in the blood instead of being used as energy. Type 1 diabetes is rare, and only 10% of people with diabetes have type 1 diabetes. It commonly occurs in childhood or adolescence. Type 2 diabetes arises when the body cannot appropriately use the insulin that is released or does not make enough insulin. As a consequence, sugar builds up in the blood instead of being used as energy. About 90% of people with diabetes have type 2 diabetes.

Oral Anti-diabetes Drugs Market: Dynamics

Increasing obese population and changing lifestyle are the factors projected to boost market growth. Advancements in technologies and reimbursement for medicines are anticipated to fuel the growth of the oral anti-diabetes drug market in the next few years. Moreover, rising incidence of diabetes is expected to increase demand for oral anti-diabetes drugs. However, ongoing research on diabetic treatment and high market potential are expected to create opportunities in the oral anti-diabetes market in the near future.

Oral Anti-diabetes Drugs Market: Segmentation

Based on dosage type, the global oral anti-diabetes drugs market has been segmented into:

  • Liquid
  • Capsule
  • Tablet

In terms of drug class, the global oral anti-diabetes drugs market has been segmented into:

  • Sulfonylureas
    • Gliclazide
    • Glyburide 
    • Glimepiride
    • Others
  • Meglitinides
    • Biguanides
    • Metformin
    • Repaglinide
    • Nateglinide
    • Others
  • Biguanides
    • Alpha-glycosidase inhibitors
    • Voglibose
    • Acarbose
    • Others
  • Others

Based on distribution channel, the global oral anti-diabetes drugs market has been segmented into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

In terms of drug class, the global oral anti-diabetes drug market has been segmented into five types: alpha-glucosidase inhibitors, meglitinides, sulfonylureas, biguanides, and others. The biguanides derivatives and sulphonylureas segments are expected to account for major shares of the global oral anti-diabetes drug market.

Oral Anti-diabetes Drugs Market: Region-wise Outlook

In terms of region, the global oral anti-diabetes drugs market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global oral anti-diabetes drugs market, followed by Europe, owing to the introduction of new products and presence of favorable government initiatives for oral anti-diabetes drugs in the region. Asia Pacific is expected to witness the fastest growth in the near future attributed to increase geriatric population in the region.

Oral Anti-diabetes Drugs Market: Key Players                

Major players operating in the global oral anti-diabetes drugs market are Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck, GlaxoSmithKline, Piramal Healthcare, Bristol-Myers Squibb, Bayer Healthcare, Dr. Reddy’s Laboratories Ltd, and Pfizer. Increasing competition among key players is expected to drive the global oral anti-diabetes drugs market during the forecast period. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market    

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.


Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top